These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 35112181)
1. Thromboprophylaxis after knee arthroscopy does not decrease the risk of deep vein thrombosis: a network meta-analysis. Lameire DL; Khalik HA; Phillips M; MacDonald AE; Banfield L; de Sa D; Ayeni OR; Peterson D Knee Surg Sports Traumatol Arthrosc; 2022 Jul; 30(7):2364-2376. PubMed ID: 35112181 [TBL] [Abstract][Full Text] [Related]
11. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials. Zhu J; Jiang H; Marshall B; Li J; Tang X Am J Sports Med; 2019 Jul; 47(8):1994-2002. PubMed ID: 30113231 [TBL] [Abstract][Full Text] [Related]
12. Deep venous thrombosis after knee arthroscopy: a systematic review and meta-analysis. Sun Y; Chen D; Xu Z; Shi D; Dai J; Qin J; Qin J; Jiang Q Arthroscopy; 2014 Mar; 30(3):406-12. PubMed ID: 24581264 [TBL] [Abstract][Full Text] [Related]
13. No effectiveness of anticoagulants for thromboprophylaxis after non-major knee arthroscopy: a systemic review and meta-analysis of randomized controlled trials. Zheng G; Tang Q; Shang P; Pan XY; Liu HX J Thromb Thrombolysis; 2018 May; 45(4):562-570. PubMed ID: 29549559 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis. Huang HF; Tian JL; Yang XT; Sun L; Hu RY; Yan ZH; Li SS; Xie Q; Tian XB PLoS One; 2018; 13(6):e0197868. PubMed ID: 29927930 [TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of low-molecular-weight heparin in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction. Li HM; Huang L; Fu J; Tong Z; Wei W; Teng C Heliyon; 2023 Sep; 9(9):e19696. PubMed ID: 37810025 [TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis. Lu X; Lin J BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575 [TBL] [Abstract][Full Text] [Related]
17. Home versus in-patient treatment for deep vein thrombosis. Othieno R; Okpo E; Forster R Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455 [TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161 [TBL] [Abstract][Full Text] [Related]
19. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568 [TBL] [Abstract][Full Text] [Related]
20. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Rasmussen MS; Jørgensen LN; Wille-Jørgensen P Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]